NovelMed Announces Positive Data On Its Humanized Antibody In Two Models Of Osteoarthritis (OA)
NovelMed Therapeutics announced today positive data using its novel, humanized monoclonal antibody in two well-established models of osteoarthritis (OA), characterized by osteophyte formation and cartilage loss
No comments:
Post a Comment